产品编号：S870000
产品规格：50mg
产品价格：面议
| 标准品编号: | S870000 |
| 名称: | Suvorexant |
| 别名: | [(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-methanone; 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole; MK 4305; [(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone |
| CAS号: | 1030377-33-3 |
| 分子式: | C₂₃H₂₃ClN₆O₂ |
| 外观: | 白色至Pale Beige Solid |
| 熔点: | 131-133°C |
| 分子量: | 450.92 |
| 储存: | Room Temperature |
| 溶解度: | Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Heated) |
| 类别: | Research Tools; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Suvorexant (MK-4305) is a dual (non-selective) orexin receptor antagonist in development by Merck & Co. for the treatment of insomnia. It works by turning off wakefulness rather than by inducing sleep. Users of higher doses had an increased rate of suicidal ideation. |
| 参考文献 | |
